[Organ preservation after short-course radiotherapy and transanal endoscopic microsurgery for early-stage rectal cancer (TREC)].
作者信息
Pochhammer Julius, Dunst Jürgen
机构信息
Chirurgische Universitätsklinik, UKSH, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland.
Klinik für Strahlentherapie, UKSH, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland.
出版信息
Strahlenther Onkol. 2021 Aug;197(8):749-751. doi: 10.1007/s00066-021-01795-0. Epub 2021 Jun 4.
Abstract
摘要
相似文献
1
[Organ preservation after short-course radiotherapy and transanal endoscopic microsurgery for early-stage rectal cancer (TREC)].
Strahlenther Onkol. 2021 Aug;197(8):749-751. doi: 10.1007/s00066-021-01795-0. Epub 2021 Jun 4.
2
Radical surgery versus organ preservation for early-stage rectal cancer.
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):263. doi: 10.1016/S2468-1253(21)00015-7.
3
Radical surgery versus organ preservation for early-stage rectal cancer - Authors' reply.
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):263-264. doi: 10.1016/S2468-1253(21)00061-3.
4
National Early Rectal Cancer Treatment Revisited.
Dis Colon Rectum. 2016 Jul;59(7):623-9. doi: 10.1097/DCR.0000000000000591.
5
Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
Dis Colon Rectum. 2017 Feb;60(2):152-160. doi: 10.1097/DCR.0000000000000764.
6
Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
Dis Colon Rectum. 2016 Apr;59(4):264-9. doi: 10.1097/DCR.0000000000000543.
7
[Radical resection versus organ preservation by short-course radiotherapy followed by transanal tumor resection for early stage rectal cancer-Results of the randomized TREC study].
Chirurg. 2022 Feb;93(2):201-202. doi: 10.1007/s00104-022-01578-y. Epub 2022 Jan 18.
8
Moving forward with organ preservation in rectal cancer.
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):82-83. doi: 10.1016/S2468-1253(20)30390-3. Epub 2020 Dec 11.
9
Chemoradiotherapy and Local Excision for Organ Preservation in Early Rectal Cancer-The End of the Beginning?
JAMA Surg. 2019 Jan 1;154(1):54-55. doi: 10.1001/jamasurg.2018.3760.
10
Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.
Surg Endosc. 2016 Nov;30(11):4841-4852. doi: 10.1007/s00464-016-4818-9. Epub 2016 Feb 22.
本文引用的文献
1
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):92-105. doi: 10.1016/S2468-1253(20)30333-2. Epub 2020 Dec 11.
2
Quality of life after rectal-preserving treatment of rectal cancer.
Eur J Surg Oncol. 2020 Nov;46(11):2050-2056. doi: 10.1016/j.ejso.2020.07.018. Epub 2020 Jul 22.
3
Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study.
Dis Colon Rectum. 2020 Jul;63(7):897-902. doi: 10.1097/DCR.0000000000001646.
4
Mesorectal radiotherapy for early stage rectal cancer: A novel target volume.
Clin Transl Radiat Oncol. 2020 Feb 4;21:104-111. doi: 10.1016/j.ctro.2020.02.001. eCollection 2020 Mar.
5
Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme.
Radiother Oncol. 2019 Mar;132:79-84. doi: 10.1016/j.radonc.2018.11.017. Epub 2018 Dec 21.
6
Can we ave the rectum by watchful waiting or ransnal microsurgery following (chemo) adiotherapy versus otal mesorectal excision for early ctal ancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.
BMJ Open. 2017 Dec 28;7(12):e019474. doi: 10.1136/bmjopen-2017-019474.
7
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
BMC Cancer. 2015 Oct 23;15:767. doi: 10.1186/s12885-015-1632-z.
8
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22.
Zotero 插件